The Chennai-based pharma major, Orchid Chemicals & Pharmaceuticals Ltd (Orchid) today announced that it has received approval from the US FDA for its ANDA (Abbreviated New Drug Application) for Amlodipine Besylate Tablets, 2.5 mg, 5 mg and 10 mg.
With this approval, Orchid's cumulative ANDA approval count stands at 32 and the total ANDA filing count stands at 58.
The stock was trading at Rs.96.10, up by Rs.0.45 or 0.47%. The stock hit an intraday high of Rs.97.30 and low of Rs.94.10.
The total traded quantity was 229900 compared to 2 week average of 382964.
|
